Prevalence and association of human parvovirus B19V with hepatitis B and C viruses in Nigeria

Journal of Medical Virology

Volumn 83, Issue 4, 2011, Pages 710-716

  Opaleye, O O ^a,b   Fagbami, A H ^b   Lalremruata, A ^a   Kun, J F J ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b LADOKE AKINTOLA UNIVERSITY OF TECHNOLOGY   (Nigeria)

Author keywords

Genotype; Hepatitis B virus; Hepatitis C virus; Human parvovirus B19; Liver disease

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIBODY; VIRUS DNA;

ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN PARVOVIRUS B19; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NIGERIA; NUCLEOTIDE SEQUENCE; PARVOVIRUS INFECTION; VIRUS CARRIER;

ADULT; ANTIBODIES, VIRAL; COMORBIDITY; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; NIGERIA; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PREVALENCE;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; PARVOVIRUS;

EID: 79951539921     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22008     Document Type: Article

References (35)

1. Agbandje M, Parrish CR, Rossmann MG. 1995. The structure of parvoviruses. Semin Virol 6: 299-309.
2. Arista S, De Grazia S, Di Marco V, Di Stefano R, Craxi A. 2003. Parvovirus B19 and 'cryptogenic' chronic hepatitis. J Hepatol 38: 375-376.
3. Bernuau J, Durand F, Valla D. 1999. Parvovirus B19 infection and fulminant hepatitis. Lancet 353: 754-755.
4. Bizjak G, Blondin D, Hammer R, Kozlowski P, Siegmann HJ, Stressig R. 2009. Acute infection with parvovirus B19 in early pregnancy. Ultrasound Obstet Gynecol 34: 234-235.
5. Booth C, Inusa B, Obaro SK. 2010. Infection in sickle cell disease: A review. Int J Infect Dis 14: E2-E12.
6. Brown CS, Vanlent JWM, Vlak JM, Spaan WJM. 1991. Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus-B19V structural proteins. J Virol 65: 2702-2706.
7. Bultmann BD, Klingel K, Sotlar K, Bock CT, Baba HA, Sauter M, Kandolf R. 2003. Fatal parvovirus B19V-associated myocarditis clinically mimicking ischemic heart disease: An endothelial cell-mediated disease. Hum Pathol 34: 92-95.
8. Buyukkose M, Kozanoglu E, Basaran S, Bayramoglu O, Yarkin F. 2009. Seroprevalence of parvovirus B19 in fibromyalgia syndrome. Clin Rheumatol 28: 305-309.
9. Cassinotti P, Siegl C, Michel B, Bruhlmann P. 1998. Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin. J Med Virol 56: 199-204.
10. Cotmore SF, Mckie VC, Anderson LJ, Astell CR, Tattersall P. 1986. Identification of the major structural and nonstructural proteins encoded by human parvovirus-B19V and mapping of their genes by prokaryotic expression of isolated genomic fragments. J Virol 60: 548-557.
11. Drago F, Semino M, Rampini P, Rebora A. 1999. Parvovirus B19 infection associated with acute hepatitis and a purpuric exanthem. Br J Dermatol 141: 160-161.
12. Grossebley A, Eishubinger AM, Kaiser R, Oldenburg J, Brackmann HH, Schwarz TF, Schneweis KE. 1994. Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs. Thromb Haemost 72: 503-507.
13. Henriques I, Monteiro F, Meireles E, Cruz A, Tavares G, Ferreira M, Araujo F. 2005. Prevalence of parvovirus B19 and hepatitis a virus in Portuguese blood donors. Transfus Apheresis Sci 33: 305-309.
14. Hillingso JG, Jensen IP, Tom-Petersen L. 1998. Parvovirus B19 and acute hepatitis in adults. Lancet 351: 955-956.
15. Hsu TC, Chen TY, Lin MC, Tzang BS, Tsay GJ. 2005. Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection. J Gastroenterol Hepatol 20: 733-738.
16. Hubschen JM, Mihneva Z, Mentis AF, Schneider F, Aboudy Y, Grossman Z, Rudich H, Kasymbekova K, Sarv I, Nedeljkovic J, Tahita MC, Tarnagda Z, Ouedraogo JB, Gerasimova AG, Moskaleva TN, Tikhonova NT, Chitadze N, Forbi JC, Faneye AO, Otegbayo JA, Charpentier E, Muller CP. 2009. Phylogenetic analysis of human parvovirus B19 sequences from eleven different countries confirms the predominance of genotype 1 and suggests the spread of genotype 3b. J Clin Microbiol 47: 3735-3738.
17. Imarengiaye CO, Enosolease ME, Iribhogbe PE, Ehigiegba AE. 2006. Risk of transfusion-transmitted hepatitis C virus in a tertiary hospital in Nigeria. Public Health 120: 274-278.
18. Karetnyi YV, Beck PR, Markin RS, Langnas AN, Naides SJ. 1999. Human parvovirus B19 infection in acute fulminant liver failure. Arch Virol 144: 1713-1724.
19. Langnas AN, Markin RS, Cattral MS, Naides SJ. 1995. Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia. Hepatology 22: 1661-1665.
20. Lee PC, Hung CJ, Lin YJ, Wang JR, Jan MS, Lei HY. 2002. A role for chronic parvovirus B19 infection in liver dysfunction in renal transplant recipients? Transplantation 73: 1635-1639.
21. Mabayoje VO, Oparinde DP, Akanni EO, Taiwo SS, Muhibi MA, Adebayo T. 2007. Seroprevalence of hepatitis B and C and of human immunodeficiency virus among blood donors in south-west Nigeria. Br J Biomed Sci 64: 177-179.
22. Nishida Y, Arai M, Yamamoto Y, Fukutake K. 1997. Serological and virological markers of human parvovirus B19 infection in patients with haemophilia. Haemophilia 3: 137-142.
23. Opaleye OO, Zakariyahu TO, Tijani BA, Bakarey AS. 2010. HBV, HCV co-infection among blood donors in Nigeria. Indian J Pathol Microbiol 53: 182-183.
24. Schneider B, Fryer JF, Reber U, Fischer HP, Tolba RH, Baylis SA, Eis-Hubinger AM. 2008. Persistence of novel human parvovirus PARV4 in liver tissue of adults. J Med Virol 80: 345-351.
25. Servant-Delmas A, Laperche S, Mercier M, Lefrere JJ. 2009a. Genetic diversity of human erythroviruses. Pathol Biol 57: 167-174.
26. Servant-Delmas A, Mercier M, Laperche S, Lefrere JJ. 2009b. Genetic diversity of human erythroviruses. Consequences on infectious safety of plasma derivatives. Transfus Clin Biol 16: 482-488.
27. Soderlund M, vonEssen R, Haapasaari J, Kiistala U, Kiviluoto O, Hedman K. 1997. Persistence of parvoviris B19V DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet 349: 1063-1065.
28. Tamura K, Dudley J, Nei M, Kumar S. 2007. MEG A4: Molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596-1599.
29. Thompson JD, Higgins DG, Gibson TJ. 1994. Clustal-W-improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-4680.
30. Toan NL, Duechting A, Kremsner PG, Song LH, Ebinger M, Aberle S, Binh VQ, Duy DN, Torresi J, Kandolf R, Bock CT. 2006a. Phylogenetic analysis of human parvovirus B19V, indicating two subgroups of genotype 1 in Vietnamese patients. J Gen Virol 87: 2941-2949.
31. Toan NL, Song LH, Kremsner PG, Duy DN, Binh VQ, Duechting A, Kaiser H, Torresi J, Kandolf R, Bock CT. 2006b. Co-infection of human parvovirus B19 in Vietnamese patients with hepatitis B virus infection. J Hepatol 45: 361-369.
32. Uneke CJ, Ogbu O, Inyama PU, Anyanwu GI, Njoku MO, Idoko JH. 2005. Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria. Mem Inst Oswaldo Cruz 100: 13-16.
33. Wong S, Young NS, Brown KE. 2003. Prevalence of parvovirus B19 in liver tissue: No association with fulminant hepatitis or hepatitis-associated aplastic anemia. J Infect Dis 187: 1581-1586.
34. Yoto Y, Kudoh T, Haseyama K, Suzuki N, Chiba S. 1996. Human parvovirus B19 infection associated with acute hepatitis. Lancet 347: 868-869.
35. Young NS, Brown KE. 2004. Mechanisms of disease-Parvovirus B19V. N Engl J Med 350: 586-597.